1,407
Views
20
CrossRef citations to date
0
Altmetric
Author's View

Tumor cell-derived microparticles: a new form of cancer vaccine

&
Article: e1017704 | Received 05 Feb 2015, Accepted 06 Feb 2015, Published online: 30 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shuangli Zhu, Shiyu Li, Ming Yi, Ning Li & Kongming Wu. (2021) Roles of Microvesicles in Tumor Progression and Clinical Applications. International Journal of Nanomedicine 16, pages 7071-7090.
Read now
Wenqian Dong, Huafeng Zhang, Xiaonan Yin, Yuying Liu, Degao Chen, Xiaoyu Liang, Xun Jin, Jiadi Lv, Jingwei Ma, Ke Tang, Zhuowei Hu, Xiaofeng Qin & Bo Huang. (2017) Oral delivery of tumor microparticle vaccines activates NOD2 signaling pathway in ileac epithelium rendering potent antitumor T cell immunity. OncoImmunology 6:3.
Read now

Articles from other publishers (18)

Sangiliyandi Gurunathan, Pratheep Thangaraj, Lin Wang, Qilong Cao & Jin-Hoi Kim. (2024) Nanovaccines: An effective therapeutic approach for cancer therapy. Biomedicine & Pharmacotherapy 170, pages 115992.
Crossref
Weiwei Sun, Pingwei Xu, Pengtao Pan, Sheng Guo, Rui Liu, Guojie Ji, Huanhuan Hu, Weidong Li & Lili Dai. (2023) Application of tumor microparticles in tumor prevention and treatment. Cancer Nanotechnology 14:1.
Crossref
Faisal Raza, Mengyuan Zheng, Hongyu Zhong, Jing Su, Beixuan He, Wei-En Yuan & Mingfeng Qiu. (2023) Engineered tumor microvesicles modified by SP94 peptide for arsenic trioxide targeting drug delivery in liver cancer therapy. Biomaterials Advances 155, pages 213683.
Crossref
Qi Tan, Zimo Yang, Shichen Bu, Jiangbin Chen, Wenjuan Chen, Wei Geng, Qi Huang, Limin Duan, Mengfei Guo, Yali Wu, Jingjing Deng, E Zhou, Minglei Li, Feng Wu & Yang Jin. (2023) Tumor-derived microparticles-based nanomaterial as platform for delivery of tumor antigens to enhance immunogenicity. Chemical Engineering Journal 464, pages 142497.
Crossref
Xinyi Zhang, Hengqing Cui, Wenjun Zhang, Zhaoshen Li & Jie Gao. (2023) Engineered tumor cell-derived vaccines against cancer: The art of combating poison with poison. Bioactive Materials 22, pages 491-517.
Crossref
Shiqi Huang, Yining Zhu, Ling Zhang & Zhirong Zhang. (2022) Recent Advances in Delivery Systems for Genetic and Other Novel Vaccines. Advanced Materials 34:46.
Crossref
Yu Liu, Sufei Wang, Hui Xia, Xueyun Tan, Siwei Song, Shujing Zhang, Daquan Meng, Qing Chen & Yang Jin. (2022) The potential applications of microparticles in the diagnosis, treatment, and prognosis of lung cancer. Journal of Translational Medicine 20:1.
Crossref
Lucrecia Agnetti, Chiara Fondello, María Florencia Arbe, Gerardo C. Glikin & Liliana M. E. Finocchiaro. (2020) Particulate mediators of the bystander effect linked to suicide and interferon-β transgene expression in melanoma cells. Gene Therapy 28:1-2, pages 38-55.
Crossref
Muhammad Babar Khawar, Muddasir Hassan Abbasi, Zerwa Siddique, Amin Arif & Nadeem Sheikh. (2019) An Update on Novel Therapeutic Warfronts of Extracellular Vesicles (EVs) in Cancer Treatment: Where We Are Standing Right Now and Where to Go in the Future. Oxidative Medicine and Cellular Longevity 2019, pages 1-21.
Crossref
Ritu Jaiswal & Lisa M. Sedger. (2019) Intercellular Vesicular Transfer by Exosomes, Microparticles and Oncosomes - Implications for Cancer Biology and Treatments. Frontiers in Oncology 9.
Crossref
Marco Dionisi, Claudia De Archangelis, Federico Battisti, Hassan Rahimi Koshkaki, Francesca Belleudi, Ilaria Grazia Zizzari, Ilary Ruscito, Christian Albano, Alessandra Di Filippo, Maria Rosaria Torrisi, Pierluigi Benedetti Panici, Chiara Napoletano, Marianna Nuti & Aurelia Rughetti. (2018) Tumor-Derived Microvesicles Enhance Cross-Processing Ability of Clinical Grade Dendritic Cells. Frontiers in Immunology 9.
Crossref
Jingwei Ma, Keke Wei, Huafeng Zhang, Ke Tang, Fei Li, Tianzhen Zhang, Junwei Liu, Pingwei Xu, Yuandong Yu, Weiwei Sun, LiYan Zhu, Jie Chen, Li Zhou, Xiaoyu Liang, Jiadi Lv, Roland Fiskesund, Yuying Liu & Bo Huang. (2018) Mechanisms by Which Dendritic Cells Present Tumor Microparticle Antigens to CD8+ T Cells. Cancer Immunology Research 6:9, pages 1057-1068.
Crossref
Thanuja M.Y. Anupama C.Sudhir H. Ranganath. (2018) Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: So near and yet so far. Advanced Drug Delivery Reviews 132, pages 57-80.
Crossref
Tingting Wu, Yan Qi, Dan Zhang, Qingle Song, Conglian Yang, Xiaomeng Hu, Yuling Bao, Yongdan Zhao & Zhiping Zhang. (2017) Bone Marrow Dendritic Cells Derived Microvesicles for Combinational Immunochemotherapy against Tumor. Advanced Functional Materials 27:42, pages 1703191.
Crossref
Federico Battisti, Chiara Napoletano, Hassan Rahimi Koshkaki, Francesca Belleudi, Ilaria Grazia Zizzari, Ilary Ruscito, Sara Palchetti, Filippo Bellati, Pierluigi Benedetti Panici, Maria Rosaria Torrisi, Giulio Caracciolo, Fabio Altieri, Marianna Nuti & Aurelia Rughetti. (2017) Tumor-Derived Microvesicles Modulate Antigen Cross-Processing via Reactive Oxygen Species-Mediated Alkalinization of Phagosomal Compartment in Dendritic Cells. Frontiers in Immunology 8.
Crossref
Bing Cui, Xuetao Cao, Weiping Zou, Yonghong Wan, Ning Wang, Yaohe Wang, Pingping Li, Fang Hua, Yuying Liu, Xiaowei Zhang, Ke Li, Xiaoxi Lv, Bo Huang & Zhuowei Hu. (2017) Regulation of immune-related diseases by multiple factors of chromatin, exosomes, microparticles, vaccines, oxidative stress, dormancy, protein quality control, inflammation and microenvironment: a meeting report of 2017 International Workshop of the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine on Tumor Immunology. Acta Pharmaceutica Sinica B 7:4, pages 532-540.
Crossref
Magdalena Surman, Ewa Stępień, Dorota Hoja-Łukowicz & Małgorzata Przybyło. (2017) Deciphering the role of ectosomes in cancer development and progression: focus on the proteome. Clinical & Experimental Metastasis 34:3-4, pages 273-289.
Crossref
Fan‑Dong Meng, Shuai Wang, You‑Hong Jiang & Cheng‑Guang Sui. (2016) Antitumor effect of dendritic cells transfected with prostate-specific membrane antigen recombinant adenovirus on prostate cancer: An in�vitro study. Molecular Medicine Reports.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.